After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
Hong Kong shareholders have foiled plans by Fosun Pharma to take its biologics subsidiary off the stock market at half the IPO price Key Takeaways: Fosun Pharma has pledged to…
FAST NEWS: VNET Receives Founder-Led Buyout Offer
The latest: Data center operator VNET Group Inc. (VNET.US) announced Tuesday its founder Chen Sheng has submitted an offer to acquire all of the company’s outstanding stock for $8.20 in cash per American…
RECENT ARTICLES
-
Fosun moves on from debt crisis with renewed focus on tourism, healthcare
0656.HK -
Fosun Tourism travels back to home base with delisting plan
1992.HK 0656.HK
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Cancer drug maker Biostar shines on Hong Kong market debut
2563.HK
-
BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
2196.HK 600196.SHG
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
